103 related articles for article (PubMed ID: 21736695)
1. Phosphodiesterase type 9 (PDE9) in the human lower urinary tract: an immunohistochemical study.
Nagasaki S; Nakano Y; Masuda M; Ono K; Miki Y; Shibahara Y; Sasano H
BJU Int; 2012 Mar; 109(6):934-40. PubMed ID: 21736695
[TBL] [Abstract][Full Text] [Related]
2. Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract.
Fibbi B; Morelli A; Vignozzi L; Filippi S; Chavalmane A; De Vita G; Marini M; Gacci M; Vannelli GB; Sandner P; Maggi M
J Sex Med; 2010 Jan; 7(1 Pt 1):59-69. PubMed ID: 19796053
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of PDE5 and PDE9 expression in benign and malignant breast tumors.
Karami-Tehrani F; Moeinifard M; Aghaei M; Atri M
Arch Med Res; 2012 Aug; 43(6):470-5. PubMed ID: 22960860
[TBL] [Abstract][Full Text] [Related]
4. Expression of the cGMP-specific phosphodiesterases 2 and 9 in normal and Alzheimer's disease human brains.
Reyes-Irisarri E; Markerink-Van Ittersum M; Mengod G; de Vente J
Eur J Neurosci; 2007 Jun; 25(11):3332-8. PubMed ID: 17553001
[TBL] [Abstract][Full Text] [Related]
5. Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study.
Oelke M; Hedlund P; Albrecht K; Ellinghaus P; Stief CG; Jonas U; Andersson KE; Uckert S
Urology; 2006 May; 67(5):1111-6. PubMed ID: 16635522
[TBL] [Abstract][Full Text] [Related]
6. mRNA expression patterns of the cGMP-hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain.
Van Staveren WC; Steinbusch HW; Markerink-Van Ittersum M; Repaske DR; Goy MF; Kotera J; Omori K; Beavo JA; De Vente J
J Comp Neurol; 2003 Dec; 467(4):566-80. PubMed ID: 14624489
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats.
Morelli A; Sarchielli E; Comeglio P; Filippi S; Mancina R; Gacci M; Vignozzi L; Carini M; Vannelli GB; Maggi M
J Sex Med; 2011 Oct; 8(10):2746-60. PubMed ID: 21812935
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide-induced changes in endothelial expression of phosphodiesterases 2, 3, and 5.
Schankin CJ; Kruse LS; Reinisch VM; Jungmann S; Kristensen JC; Grau S; Ferrari U; Sinicina I; Goldbrunner R; Straube A; Kruuse C
Headache; 2010 Mar; 50(3):431-41. PubMed ID: 19751368
[TBL] [Abstract][Full Text] [Related]
9. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
de Vente J; Markerink-van Ittersum M; Vles JS
J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
[TBL] [Abstract][Full Text] [Related]
10. Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6.
White JB; Thompson WJ; Pittler SJ
Mol Vis; 2004 Oct; 10():738-49. PubMed ID: 15480303
[TBL] [Abstract][Full Text] [Related]
11. Qualitative and quantitative expression profile of muscarinic receptors in human urothelium and detrusor.
Tyagi S; Tyagi P; Van-le S; Yoshimura N; Chancellor MB; de Miguel F
J Urol; 2006 Oct; 176(4 Pt 1):1673-8. PubMed ID: 16952712
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical distribution of cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human vagina: a potential forensic value?
Albrecht K; Uckert S; Oelke M; Andersson KE; Jonas U; Tröger HD; Hedlund P
J Forensic Leg Med; 2007 Jul; 14(5):270-4. PubMed ID: 17113813
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis.
Netherton SJ; Maurice DH
Mol Pharmacol; 2005 Jan; 67(1):263-72. PubMed ID: 15475573
[TBL] [Abstract][Full Text] [Related]
14. Improving erectile function by silencing phosphodiesterase-5.
Lin G; Hayashi N; Carrion R; Chang LJ; Lue TF; Lin CS
J Urol; 2005 Sep; 174(3):1142-8. PubMed ID: 16094082
[TBL] [Abstract][Full Text] [Related]
15. Expression of messenger ribonucleic acid encoding for phosphodiesterase isoenzymes in human female genital tissues.
Uckert S; Ellinghaus P; Albrecht K; Jonas U; Oelke M
J Sex Med; 2007 Nov; 4(6):1604-9. PubMed ID: 17888073
[TBL] [Abstract][Full Text] [Related]
16. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
[TBL] [Abstract][Full Text] [Related]
17. Changes of M3-muscarinic receptor protein and mRNA expressions in the bladder urothelium and muscle layer of streptozotocin-induced diabetic rats.
Cheng JT; Yu BC; Tong YC
Neurosci Lett; 2007 Aug; 423(1):1-5. PubMed ID: 17630213
[TBL] [Abstract][Full Text] [Related]
18. Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens.
Mancina R; Filippi S; Marini M; Morelli A; Vignozzi L; Salonia A; Montorsi F; Mondaini N; Vannelli GB; Donati S; Lotti F; Forti G; Maggi M
Mol Hum Reprod; 2005 Feb; 11(2):107-15. PubMed ID: 15640438
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterases (PDEs) and PDE inhibitors for treatment of LUTS.
Andersson KE; Uckert S; Stief C; Hedlund P
Neurourol Urodyn; 2007 Oct; 26(6 Suppl):928-33. PubMed ID: 17806124
[TBL] [Abstract][Full Text] [Related]
20. Characterization of renal ecto-phosphodiesterase.
Jackson EK; Ren J; Zacharia LC; Mi Z
J Pharmacol Exp Ther; 2007 May; 321(2):810-5. PubMed ID: 17308037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
